The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 29, 2010

Filed:

Jun. 20, 2007
Applicants:

Takaomi Saido, Wako, JP;

Nobuhisa Iwata, Wako, JP;

Takashi Saito, Wako, JP;

Takahiro Suemoto, Wako, JP;

Jiro Takano, Wako, JP;

Inventors:

Takaomi Saido, Wako, JP;

Nobuhisa Iwata, Wako, JP;

Takashi Saito, Wako, JP;

Takahiro Suemoto, Wako, JP;

Jiro Takano, Wako, JP;

Assignee:

Riken, Wako-shi, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/033 (2006.01); G01N 33/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides a non-human model mammal of Alzheimer's disease (AD) containing chimeric amyloid precursor protein (APP) gene capable of producing human amyloid β peptide (Aβ) or a living part thereof, characterized in that Aβ42/Aβ40 ratio at 8-weeks-old is about 7-fold or more (about 140-fold or more in homozygote) higher compared to that of a corresponding wild-type mammal. Moreover, the present invention provides the mammal or a living part thereof, further characterized in that the level of APP expression is not significantly different compared to the corresponding wild-type mammal, and a screening method for a prophylactic and/or therapeutic drug for AD, a biomarker in biological fluids and molecular imaging of amyloid deposition or other pathological changes in the brain for an early diagnosis of AD using the mammal or a living part thereof.


Find Patent Forward Citations

Loading…